Blurbs

Raymond James Sings the Praises of Adamis Pharmaceuticals; Here’s Why

What does the future hold for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)? Raymond James analyst Elliot Wilbur is out today with a bullish note on …

Investing Guru Jim Simons Rolls Out the Red Carpet for Valeant Pharmaceuticals, Cuts Opko Health

Jim Simons, the founder of one of the world’s most successful hedge funds, is splashing out on controversial healthcare stock Valeant Pharmaceuticals (NYSE:VRX). …

Bluebird Bio (BLUE) Bullish Camp Just Got Stronger

Bluebird Bio Inc (NASDAQ:BLUE) just attracted another bull to its biotech table, with Canaccord analyst John Newman believing the company’s collaboration with Celgene …

Himax Is Not Looking Too Hot for 2018, Says Rosenblatt

Himax Technologies (NASDAQ:HIMX) is a semiconductor company that may have met its match: lackluster 3D sensing revenue just around the corner. Rosenblatt analyst …

Pyxis Tankers Inc. (PXS) Downgraded After Reaching $9 Due to Expensive Valuation

Analyst James Jang and his team cut their rating on Pyxis Tankers Inc (NASDAQ:PXS) from Buy to Hold, with a $3.00 price target.

Is Valeant Cured of Headwinds? Analyst Sheds Light Following Meeting with Management

Valeant Pharmaceuticals (NYSE:VRX) management boiled down its position to BTIG analyst Tim Chiang, where the discussion gravitated on the standing of the company’s …

Oppenheimer Bullish on Nutanix’s Transition; Boosts Price-Target

Nutanix Inc. (NASDAQ:NTNX) keeps producing earnings results that blow away Wall Street estimates, says Oppenheimer analyst Ittai Kidron in raising his price target on …

This Bull Cheers for Adamis Pharmaceuticals Following PAS Submission for Pediatric Version of Epinephrine Auto-Injector Symjepi

Adamis Pharmaceuticals (NASDAQ:ADMP) investors sent the stock on a nearly 9% gain in value yesterday on back of the news of the company’s …

Tigress Makes Bullish Case for Alibaba’s Strong Future Growth Opportunities

Alibaba Group (NYSE:BABA) is on a roll after a record-profitable Singles Day, China’s gift of an anti-Valentine’s Day for singles in terms of …

Roth Capital Gets Even More Bullish on Himax Pointing to Stable iPhone Demand for 4Q

Roth Capital analyst Suji Desilva is bumping up the assurance factor when it comes to Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) and its opportunity …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts